Clinical Trials Directory

Trials / Conditions / Oncology Patients

Oncology Patients

15 registered clinical trials studyying Oncology Patients — 2 currently recruiting.

StatusTrialSponsorPhase
SuspendedFOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
NCT06800053
Charles KamenN/A
RecruitingUtilization of Virtual Reality to Increase Comfort and Reduce Procedural Distress During Port Insertion Into t
NCT06927804
University Hospital OstravaN/A
RecruitingOncology Legal Navigation Study
NCT07443839
Jean EdwardN/A
CompletedEffect of the Benson Relaxation Technique on Clinical Outcomes of Oncology Patients Admitted to Intensive Care
NCT06661239
Damanhour UniversityN/A
CompletedThe Effect of Reiki on Hopelessness Level
NCT06954506
Saglik Bilimleri UniversitesiN/A
UnknownIssues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic
NCT04406844
Max Healthcare Insititute Limited—
TerminatedSafety Study of AMG 228 to Treat Solid Tumors
NCT02437916
AmgenPhase 1
CompletedA Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
NCT02110355
Kartos Therapeutics, Inc.Phase 1
CompletedA Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
NCT02016729
Kartos Therapeutics, Inc.Phase 1
CompletedA Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
NCT01723020
Kartos Therapeutics, Inc.Phase 1
CompletedQUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
NCT01231347
NantCell, Inc.Phase 3
CompletedAMG 319 Lymphoid Malignancy FIH
NCT01300026
AmgenPhase 1
CompletedA Study of AMG 337 in Subjects With Advanced Solid Tumors
NCT01253707
AmgenPhase 1
CompletedA Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
NCT00813384
AmgenPhase 1
CompletedA Study of AMG 820 in Subjects With Advanced Solid Tumors
NCT01444404
AmMax Bio, Inc.Phase 1